chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received shot in left arm. About one hour after receiving the shot, I started getting very severe pain in my upper right arm that slowly spread to the right side of my neck. My right ear began to feel slightly funny, but no pain. Was going to the hospital but the all the pain went away after about 15 to 20 minutes. No problems after that so I didn't go to the hospital. I did not take any medication.
Herpes zoster (2/9/03) 2 wks after anthrax injection
Vaccination adverse reaction; Common cold; Tiredness; This spontaneous case was reported by a non-health professional and describes the occurrence of IMMUNISATION REACTION (Vaccination adverse reaction), NASOPHARYNGITIS (Common cold) and FATIGUE (Tiredness) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Rheumatoid arthritis.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On 22-Jun-2016, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 Milligram, Solution for injection. On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Dec-2021, the patient experienced IMMUNISATION REACTION (Vaccination adverse reaction), NASOPHARYNGITIS (Common cold) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, IMMUNISATION REACTION (Vaccination adverse reaction), NASOPHARYNGITIS (Common cold) and FATIGUE (Tiredness) had not resolved.            No concomitant medication information was provided. It was unknown if patient was enrolled in a covid-19 vaccine trial. Primary reporter did not have the lot number information, because the packaging was discarded. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Shortly after receiving the shot, she noticed a small knot at site & itching. Shot was given on top of tattoo which she thought was the problem. Patient treated with calamine lotion, is still having itching & small swelling.
Adverse events:  Delayed bursitis of both elbows and left knee lasting 12-14 weeks. Recipient received first dose in right arm and second dose 4 weeks later in left arm. About 7 weeks after first dose in right arm, recipient presented Olecranon bursitis of the right elbow (Popeye elbow) that lasted about 6 weeks.  About 8 weeks after second dose in left arm, recipient presented Olecranon bursitis of the left elbow that lasted about 6 weeks.  The recipient's left knee also presented swelling over the 12 week duration of the two bursitis incidents, resulting in pain while walking and restricted range of motion. 14 weeks following the second dose, the elbow bursitis and knee swelling have improved.
In 4 hours my throat began to hurt, my glands hurt, my nose ran. I had itchy eyes that burned and were bloodshot. I developed a headache. I became dizzy, my temperature went up to 103.8 degrees F. were it stayed for 12 hours. I had nausea and chills. I shook so bad I could not drink. My chest hurt.
pain at injection site after an hour which then spread to rest of arm.; headache, not that bad, foggy, developed about 8 hours after injection, still experiencing it.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site after an hour which then spread to rest of arm.) and HEADACHE (headache, not that bad, foggy, developed about 8 hours after injection, still experiencing it.) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site after an hour which then spread to rest of arm.) and HEADACHE (headache, not that bad, foggy, developed about 8 hours after injection, still experiencing it.). At the time of the report, VACCINATION SITE PAIN (pain at injection site after an hour which then spread to rest of arm.) had not resolved and HEADACHE (headache, not that bad, foggy, developed about 8 hours after injection, still experiencing it.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Brain fog. Suddenly, I'm going about doing something and as I'm about to think of something or remember something, suddenly my mind is just blank. It's pretty intense that I've been noticing it. Fogginess will last 5-10 seconds before I can recall or think of what I was going to think of. During an episode, I realized that I'm having the brain fog and I could just not recall what it was. Examples: what I was about to do, what I was going to look up, etc. Once it clears, it comes to mind what I was thinking of.
I am in bad shape here, I have had everything it's a bad situation; I have been in bed for two days; Swelling; Chills; Headache; Muscle pain; Joint pain; Slight fever; This is a spontaneous report from a contactable consumer (patient reported himself). A 79-year-old male patient received BNT162B2 (Formulation: Solution for injection, NDC number/UPC number: Unknown (there was nothing over here, there was nothing on the card), Expiry Date: Unknown (it was not there)) via an unspecified route of administration on an unspecified date at single dose to his right arm for Covid-19 immunization. The patient's medical history included ongoing blood pressure. Concomitant medication included hydrochlorothiazide (HCT) from an unspecified date and ongoing at 50 mg once a day for blood pressure. Consumer stated, "it was a pill" (not clarified further). It was reported that, about two days ago on 10Feb2021, he was in bad shape here, he have had everything it was a bad situation. He had been in bed for two days. On 10Feb2021, the patient experienced swelling, chills, headache, muscle pain, joint pain and slight fever. Consumer stated "It looked like lot number L8982 and then the next one was, it was two lot number on here, the second dose is 813248." Consumer stated "he just reported all the symptoms that, he took vaccine and he was in bad shape here, he had been in bed for two days. He got swelling, chills, had everything, it was a bad situation, got headaches, muscle pain, joint pain slight fever, right he got all." Consumer confirmed it was Pfizer vaccine, however name was not clarified. When probed for age, consumer stated, "he started feeling the symptoms about two days ago. He did not understand." Consumer stated, "about two days ago 10Feb2021." (not clarified further). When probed for the name of the Centre where patient was administered the vaccine, consumer stated, "The VA, that's the service, he was in the service the (state name) VA." Regarding lot number, consumer stated, "It looked like lot number L8982 and then the next one was, it was two lot number on here, the second dose is 813248." (Not clarified further). Consumer stated, "he did not see dose." When probed if still experiencing the problems (event not specified), consumer stated, "yeah, it was been improving a little bit, not much". (not clarified further). The patient received paracetamol (TYLENOL) as a treatment for the events. Regarding the treatment, consumer stated, "he did not know, he took it over the counter that's all he knew." Outcome of the events was unknown.  Information of lot/batch number has been requested.
Possible auto-inoculation. Before bed, on night of 07/07, patient noted redness and swelling under left eye, and 2 small red lesions under lateral canthus of right eye. Suspects that while he was playing tennis the prior 1-2 weeks, he wiped face with shirtsleeve covering vaccine site. Kept site covered with dressing and semipermeable dressing during sports activity, but with perspiration and humidity, outer dressing adhesive loosened. No visual symptoms or pain. Seen at Clinic on 7/8/03, and no abnormalities on eye exam, except as noted above; area under left eye approx. 2cm x 1 cm; no drainage; nonpruritic (conjunctiva pink; no lesions on eyelids; ophthal. exam normal); no other lesions noted on face or in nares. Patient to follow-up at Clinic in 1 week. No treatment initiated at this time. Reviewed precautions, and will take benadryl if itching occurs.
This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions/allergies and concomitant medications was not reported. On 13-JAN-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, "10PK-0.5ml SD-PFS LLok wTip" which had the lot # K009874 with expiration date on 19-MAR-2016, (dosage number and route of administration were not reported). Nonetheless, no adverse effects were reported and no product quality complaint was involved. On an unspecified date, the vaccine experienced two temperature excursions of 48 hours and other of 40 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius) and the highest recorded temperature was 47 F (8.333333333 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
The left side of my body feels tingling and numbness; tingling on the left side of my mouth; This is a spontaneous report from a contactable consumer (patient herself). A 54-year-old non-pregnant female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EN6200, Expiry Date: unknown) on 22Feb2021 15:00 via unspecified route of administration in the left arm on at single dose for COVID-19 immunization. The patient denied any medical history. She had no known allergies. The patients concomitant medications were not reported. Subsequently at the same time, after receiving the vaccine, the patient felt tingling and numbness in left side of her body. It started on her left calf, and she could mostly feel numbness and tingling on the left side of her mouth. The reporter assessed the events as non-serious. No emergency room or physician office was involved. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19. There were no relevant test. It was unknown if the patient received treatment. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Head ache  for about a week and felt bad Ringing ears- started after first shot and got worse after the second shot
Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/27/2023 Discharge Date: Feb 2, 2023  PRESENTING PROBLEM: Shortness of breath [R06.02] Lightheadedness [R42] Chest pain, unspecified type [R07.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 42-year-old woman who presented to emergency department due to shortness of breath.  She was positive for COVID in the emergency department and also found to be hypotensive.  She has a history of long haul COVID.  On further evaluation she was hypoxic in 80s with ambulation.  She was immediately started on Decadron.  Her blood pressures did respond to IV fluids however it continued to be soft in 90s.  Cortisol level was checked which was low.  Endocrine was consulted who thought the patient's cortisol level is low because of Decadron use and most likely this is contributing to her low blood pressures.  Decadron was stopped as patient remained on room air.  Patient was started on hydrocortisone which improved her blood pressures.  Echocardiogram was obtained during this admission which was within normal limits.  CT angiogram thorax was negative for pulmonary embolism as well.  Patient was doing well however suddenly again became hypoxic with ambulation r hence was restarted on Decadron after discussing with Endocrine.  Hydrocortisone was stopped.  Patient blood pressure remained stable in spite of stopping hydrocortisone.  She was discharged home with prescription for Decadron to finish total of 10 days.  At the time of discharge he was evaluated by Pulmonary in have and did not require home oxygen .  She was feeling significantly better with improvement in all her symptoms related to COVID and hypotension at the time of discharge.  Orthostatics were also checked which were negative during this admission.
This spontaneous report was received from a registered pharmacist refers to a female patient of unknown age. The pharmacist reported that an anonymous woman developed shingles after kissing an anonymous patient that on an unknown date, was vaccinated with ZOSTAVAX (dose, route and lot not reported. The outcome of the event was unknown. The relatedness between the event and ZOSTAVAX was unknown. Additional information has been requested.
I developed chest pain about a week after my second dose. I was told that I have a spontaneous pneumothorax when I went to the hospital, this initial pneumothorax turned into a series of my lungs collapsing I had a total of 6 pneumothorax over the period of the next three months. I had multiple hospitalizations with multiple chest tubes and  four surgeries ( chemical/ mechanical pleurodesis). I have never had any issues with breathing or my lungs prior to this vaccine. Throughout my hospitalizations I was diagnosed with Lymphangioleiomyomatosis, however, I wondered if there was a inflammatory reaction to the vaccine that exacerbated things because prior to the vaccine I had no issue breathing.
triggered auto-immune psoriatic arthritis; warm to touch; quarter size red mark at the injection site; itches once in a while; This spontaneous case was reported by a consumer and describes the occurrence of PSORIATIC ARTHROPATHY (triggered auto-immune psoriatic arthritis) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included TRIAMCINOLONE, FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ALLEGRA D), OMEPRAZOLE and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (WIXELA INHUB) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PSORIATIC ARTHROPATHY (triggered auto-immune psoriatic arthritis) (seriousness criterion medically significant), VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (quarter size red mark at the injection site) and VACCINATION SITE PRURITUS (itches once in a while). At the time of the report, PSORIATIC ARTHROPATHY (triggered auto-immune psoriatic arthritis), VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (quarter size red mark at the injection site) and VACCINATION SITE PRURITUS (itches once in a while) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: Upon internal review on 16-SEP-2022 non significant corrections performed to update case received from field; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Information has been received from a consumer concerning his 25 year old god-daughter who, 4 or 5 months ago, in approximately February 2009, was vaccinated with her first dose of GARDASIL (route and site not reported). About a week later the patient experienced numbness on her lower body. When the patient sought medical attention, she underwent MRI and other various tests and the doctors diagnosed her with multiple sclerosis (MS). At the time of reporting the patient's multiple sclerosis persisted. Upon internal review, multiple sclerosis was considered to be an other important medical event. This is one of several reports received from the same source. Additional information has been requested. 10/2/09 Medical records received for Neurologist consultation for dates of service 6/30/09 and 7/15/09. DX: MS.  Presenting symptoms: initial episode of left arm and leg numbness and hives 1 day after gardasil vaccination. Later 5/09 episode numbness from navel down, abnormal sensation in both legs, bowel and bladder incontinence, later resolved. Vertigo.
The arm had a little knot then it went down the it continue to ache with pain, I started taking Tynelno 500 for pain and it didn?t calm down pain got worst, where my back started to pain on left side up my neck! My neck hurts so bad on the left side! When I turn my neck it hurts!
I diagnosed with Grave's disease and acute Hashimoto's thyrotoxicosis based upon lab drawn on 2/17/2022 He presented with fatigue and activity intolerance which had progressed in the weeks since he received Pfizer COVID 19 vaccine at a pharmacy. Both anti-thyroid peroxidase antibody and thyrotropin receptor antibodies were significantly elevated. Thyroid ultrasound with diffuse enlargement and hypervascularity He is currently prescribed beta-blocker and methimazole and will follow-up for lab and with his primary care provider. He also has been referred to endocrinology and that visit is scheduled
FEVER STARTING 48 HOURS AFTER INJECTION; RED, RAISED KNOT DEVELOPED; HEADACHE
Developed significant left axillary swelling and soreness - lasted about 2.5 to 3weeks - 1st shot was worse than the 2nd
Information has been received from a nurse practitioner concerning a 16 year old patient who on an unspecified date was vaccinated with a first dose of Gardasil (lot# unknown).  The first dose had no adverse events.  On an unspecified date the patient was vaccinated with a second dose of Gardasil (lot# unknown).  The patient complained of nausea and threw up after getting home.  The patient also complained of dizziness.  The patient was not hospitalized.  On an unspecified date the patient recovered.  Additional information has been requested.  01/07/2008 This is in follow-up to report(s) previously submitted on 9/17/2007. Follow-up information was received. The nurse reported that on 20-AUG-2007, the patient experienced nausea, vomiting and no fever for 2 days. Not related to the vaccine. On an unspecified date the patient recovered. Additional information is not expected.
Patient is a 22-year-old who was admitted to the hospital at the end of November due to chest pain and pressure, along with generalized malaise.  He had recently received his second COVID-vaccine.  He was found to have elevated troponin, with a decreasing trend.  Echocardiogram showed no significant abnormalities.  His chest pain continued after hospital discharge, but gradually resolved.  He had no other new symptoms, other than a sporadic squeezing/ache of the pectoralis minor in the left anterior axillary region which improved with range of motion. Documented myocarditis with his second COVID-vaccine administration.
Swollen, erythematous, warm arm approximately 3 hours after vaccine. Given prednisone.
I don't remember if these symptoms started after taking the 1st or 2nd dose, but I developed a fever and flu-like symptoms. Later I developed a chronic cough. I am taking medicine  to deal with the cough, but it has not gone away. On June 5th 2021, I went to the Emergency Room because I was coughing all night long and I couldn't breathe well. I took many tests when I was at the ER. I was recommended to see a Pulmonologist. They prescribed me with Omeprazole and Benzonatate medication. I was also told by them that I had scarring and inflammation of my lungs. My primary care doctor prescribed Zinc, Vitamin B-12, and Fish oil.
52 year old female who has completed a 15-minute observation period with the following signs and symptoms of an adverse reaction: loss of consiousness and other - hypertension. Moderna COVID-19 vaccine# 2 in series administered.  Action(s) taken: Transferred to higher level of care Allergy to COVID-19 vaccine documented in Allergies activity: Yes Patient advised to discuss second dose considerations with a clinician
Covid-arm.  Painful rash, 3 inches from injection site, itchy and swollen.  I had the vaccine on Thursday and the reaction started on Sunday.  It is worse today.
Patient, who is a retired physician, describes an intense pain, unrelieved by over-the-counter pain medications as well as prescription opioids and muscle relaxants starting day of injection, though not immediately following vaccine administration. The pain was located around the injection site and traveled up the arm near the scapula. She describes the pain as sharp and stabbing and left her unable to move her arm. She reports the pain is better one week later but is still present. As a previous physician, she describes it as a neuritis-like pain.
loss of peripheral vision (like when you have a migraine coming on...flashing lights, etc), followed by a bad "sinus type" headache.  Took sinus medicine and it made little difference although the peripheral vision thing cleared up almost immediately.
Chronic headache with no relief.  Intermittent spikes of severe pain in ?center of brain?.  Occasional ?blackouts? associated with severe pain, which appear to be seizure-like.  Note that influenza vaccine was administered at the same time in opposite arm.  Records of manufacturer and lot number are unavailable at the time of filing this report.
Seen in clinic on 07/21/2005 for axilla pain after immunization on 07/19/2005, temperature - 97.9 degrees oral.
4 x 6 cm red edematous puritic area distal to injection site with 24 hrs of vaccine administration.
0.25 mL dose was administered instead of 0.5 mL. It was suppose to be consumer's 2nd Moderna dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (0.25 mL dose was administered instead of 0.5 mL. It was suppose to be consumer's 2nd Moderna dose.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 15-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (0.25 mL dose was administered instead of 0.5 mL. It was suppose to be consumer's 2nd Moderna dose.). On 15-Dec-2021, ACCIDENTAL UNDERDOSE (0.25 mL dose was administered instead of 0.5 mL. It was suppose to be consumer's 2nd Moderna dose.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.
This spontaneous report was received from a Licensed Practical Nurse (L.P.N.) refers to a 37 year old patient of an unknown gender. Medical history and concurrent conditions were not provided. On an unknown date, the patient was inadvertently administered a dose of (Oka-Merck) PROQUAD lot # L024497, expiration date: 01-JAN-2017, subcutaneously (dose was not reported). No adverse effect reported. There was no concomitant medication provided. Additional information is not expected because the reporter refused additional contact.